ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 77 filers reported holding ONCOCYTE CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $144,000 | -38.7% | 160,238 | +1.4% | 0.02% | -31.2% |
| Q1 2022 | $235,000 | -57.0% | 158,004 | -37.4% | 0.03% | -53.6% |
| Q4 2021 | $547,000 | +153.2% | 252,298 | +570.3% | 0.07% | +187.5% |
| Q2 2021 | $216,000 | -6.9% | 37,641 | -15.7% | 0.02% | -36.8% |
| Q1 2021 | $232,000 | -43.0% | 44,626 | -73.8% | 0.04% | -43.3% |
| Q4 2020 | $407,000 | +45.9% | 170,146 | -15.4% | 0.07% | +42.6% |
| Q3 2020 | $279,000 | – | 201,047 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 23,353,697 | $17,048,000 | 1.30% |
| AWM Investment Company, Inc. | 7,746,557 | $5,655,000 | 0.86% |
| PURA VIDA INVESTMENTS, LLC | 18,056,274 | $13,181,000 | 0.76% |
| Defender Capital, LLC. | 2,551,980 | $1,883,000 | 0.74% |
| Penbrook Management LLC | 563,350 | $411,000 | 0.35% |
| ACT CAPITAL MANAGEMENT, LLC | 330,000 | $241,000 | 0.33% |
| CALIBER WEALTH MANAGEMENT, LLC | 75,120 | $55,000 | 0.04% |
| Fort Sheridan Advisors LLC | 135,000 | $99,000 | 0.03% |
| Orbimed Advisors | 1,882,768 | $1,374,000 | 0.03% |
| WEALTH EFFECTS LLC | 51,000 | $37,000 | 0.02% |